Acasti Pharma Inc. (ACST) |
| 3.37 0.13 (4.01%) 10-25 16:00 |
| Open: | 3.4268 |
| High: | 3.448 |
| Low: | 3.2 |
| Volume: | 27,682 |
| Market Cap: | 34(M) |
| PE Ratio: | -2.36 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
| sell | buy | |||
| Resistance 2: | |
| Resistance 1: | |
| Pivot price: | |
| Support 1: | |
| Support 2: | |
| 52w High: | 3.6 |
| 52w Low: | 1.98 |
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Financials
| EPS | |
| Book Value | |
| PEG Ratio | |
| Gross Profit |
| Profit Margin (%) | |
| Operating Margin (%) | |
| Return on Assets (ttm) | |
| Return on Equity (ttm) |
Company news
Thu, 24 Apr 2025
ACST Stock Price, News & Analysis - Stock Titan
Sat, 28 Dec 2024
Acasti Pharma (NASDAQ: ACST) - Share Price - intelligentinvestor.com.au
Fri, 25 Oct 2024
Acasti Announces Corporate Name Change to Grace Therapeutics, Inc. - Yahoo Finance
Wed, 10 Jul 2024
Is Acasti Pharma (ACST) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Mon, 12 Feb 2024
Acasti: Fiscal Q3 Earnings Snapshot - qz.com
Fri, 07 Jul 2023
Acasti Pharma Announces 1-for-6 Reverse Stock Split - ChartMill
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
